Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

AFQ056 for Language Learning in Children With FXS

ClinicalTrials.gov ID: NCT02920892

Public ClinicalTrials.gov record NCT02920892. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 9:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effects of AFQ056 on Language Learning in Young Children With Fragile X Syndrome (FXS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical trial is to investigate the impact of AFQ056 on language learning in 3-6 year old children with Fragile X Syndrome (FXS).

Study identification

NCT ID
NCT02920892
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Elizabeth Berry-Kravis
Other
Enrollment
110 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
32 Months to 6 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 17, 2017 (Actual)
Primary completion
May 17, 2022 (Actual)
Completion
May 17, 2022 (Actual)
Last update posted
Oct 10, 2023

2017 – 2022

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
Univeristy of California - Davis Davis California 95817 —
Children's Hospital of Colorado Denver Colorado 80045 —
Yale University New Haven Connecticut 06520 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Emory University Atlanta Georgia 30033 —
Rush University Medical Center Chicago Illinois 60612 —
Boston Children's Hospital Boston Massachusetts 02115 —
St Louis Children's Hospital (Washington University School of Medicine) St Louis Missouri 63110 —
Columbia University - New York Presbyterian New York New York 10605 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02920892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 10, 2023 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02920892 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →